Our VP CMC development, Christine Hägglund, has been interviewed in the magazine Life Science Sweden. In the article, you can read about how a small company in Sweden can be so far ahead in vaccines against diarrheal diseases. Read the full article here
We are looking for a senior project manager with experience and interest in leading complex pharmaceutical manufacturing and development projects from phase III to commercialization. We have an exciting journey ahead of us and we hope you want to join us on this journey! For more information about the role as CMC Project Lead click […]
Scandinavian Biopharma is pleased to inform that Christine Hägglund has been recruited as Scandinavian Biopharmas VP CMC Development. Christine holds a PhD in Biochemistry and has almost 20 years of experience in drug development of biological pharmaceuticals. Most recently, she comes from the position of Director of Analytical Science & Technology at Sobi. “I really […]
Join us when we are expanding. We are now looking for both a Senior Scientist and a Scientist with experience and interest in drug development in the late clinical phase. Join us in our work to give people worldwide a longer and better life. We are an entrepreneurial company and experts in global vaccine development, manufacturing, […]
We are proud to announce that all participants have received the third and final vaccination dose in our large randomized, placebo-controlled, and double-blind phase IIb study in The Gambia. The study started in 2021 and is part of the late phase development program in Africa for Scandinavian Biopharma’s vaccine candidate, ETVAX®, against Enterotoxigenic Escherichia coli […]
Join us when we are expanding our unit with another Clinical Project Manager. In this role, you will lead the planning, execution and documentation of clinical studies for our late clinical phase vaccine products. Join us in our work to give people worldwide a longer and better life. We are an entrepreneurial company and experts […]
